Anixa Biosciences (ANIX) Inventory (2010 - 2011)
Anixa Biosciences' (ANIX) quarterly Inventory came in at $33361.0 in Q3 2011, down 35.81% on a QoQ basis from $51972.0 in Q4 2010.
Anixa Biosciences (ANIX) Inventory (2010 - 2011) Analysis & Trends
Anixa Biosciences (ANIX) has 2 years of Inventory data on file, last reported at $33361.0 in Q3 2011.
- Quarterly Inventory changed N/A year-over-year to $33361.0 in Q3 2011, while the trailing twelve-month figure through Jul 2011 was $33361.0 (changed N/A YoY) and the FY2010 annual result came in at $51972.0, changed N/A from the prior year.
- Inventory declined to $33361.0 in Q3 2011, from $51972.0 in the prior quarter.
- In the past five years, Inventory ranged from a high of $51972.0 in Q4 2010 to a low of $33361.0 in Q3 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | - |
| 10 | Anixa Biosciences | 124.96 Mn | 124.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2011 | 33,361.00 |
| Oct 31, 2010 | 51,972.00 |